Secondary leukaemia characterised by monosomy 7 occurring post-autologous stem cell transplantation for AML

Bone Marrow Transplantation

Volumn 21, Issue 8, 1998, Pages 853-855

  Rege, K P ^a   Janes, S L ^a   Saso, R ^a   Min, T ^b   Swansbury, J ^b   Powles, R L ^a   Treleaven, J G ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

AML; Autologous stem cell transplantation; Monosomy 7

Indexed keywords

ALKYLATING AGENT; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; RETINOIC ACID; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHROMOSOME ABERRATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SECOND CANCER; STEM CELL TRANSPLANTATION;

EID: 0031943531     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701181     Document Type: Article

References (10)

1. Williams CJ. Leukaemia and cancer chemotherapy. Br Med J 1990; 301: 73-74.
2. Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukaemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukaemia. Blood 1995; 86: 3562-3552.
3. Van Leeuwen F. Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment. Baillière's Clin Haematol 1996; 9: 57-85.
4. Raynaud SD, Brunet B, Chischportich M et al. Recurrent cytogenetic abnormalities observed in complete remission of acute myeloid leukaemia do not necessarily mark preleukaemic cells. Leukemia 1994; 8: 245-249.
5. Bseiso AW, Kantarjian H, Estey E. Myelodysplastic syndrome following successful therapy of APL. Leukemia 1997; 11: 168-173.
6. Kumar L. Secondary leukaemia after ABMT. Lancet 1995, 345: 810.
7. Deeg HJ, Witherspoon RP. Risk factors for the development of secondary malignancies after marrow transplantation. Hematol/Oncol Clin N Am 1993; 7: 417-429.
8. Bhatia S, Ramsay NKC, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633-3639.
9. Traweek ST, Slovak ML, Nademanee AP et al. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 1994; 84: 957-963.
10. Miller JS, Arthur DC, Litz CE et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83: 3780-3786.